GlassScriptPhysician profile
Julia T Tran
NPI 1891008629
$6,259.64
in general payments reported to CMS, 2019-2025
14 companies · $582 in 2025
The $582 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $989 · 2020: $331 · 2021: $366 · 2022: $2,048 · 2023: $970 · 2024: $974 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,463 · Travel and Lodging: $62.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,463.46 |
| Travel and Lodging | $62.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $3,097.16 | 2019-2025 | Acuvue |
| Coopervision INC. | $1,135.48 | 2023-2025 | Misight Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $591.71 | 2021-2025 | Dailies Total1, Precision7, Dailies Aqua Comfort Plus |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $345.43 | 2019-2021 | |
| Visioneering Technologies, INC. | $326.27 | 2019 | |
| Sun Pharmaceutical Industries INC. | $244.96 | 2023-2025 | |
| Allergan, INC. | $123.37 | 2021-2022 | |
| Abb Con-Cise Optical Group LLC | $117.78 | 2019 | |
| Carl Zeiss Meditec, INC. | $78.90 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $61.32 | 2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $54.59 | 2022 | |
| Shire North American Group INC | $34.71 | 2019 | |
| Biotissue Holdings INC. | $24.06 | 2023 | |
| Abbvie INC. | $23.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.